Sulindac for polyposis of the colon

Journal of Surgical Oncology

Volumn 24, Issue 1, 1983, Pages 83-87

  Waddell, William R ^a   Loughry, Richard W ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

colon polyposis; Gardner's syndrome; nonsteroid antiinflammatory drugs; prostaglandins; sulindac

Indexed keywords

INDOMETACIN; PROSTAGLANDIN; SULINDAC;

CLINICAL ARTICLE; COLON POLYPOSIS; COLONOSCOPY; DIGESTIVE SYSTEM; DRUG THERAPY; GARDNER SYNDROME; HEREDITY; HUMAN; LARGE INTESTINE; ORAL DRUG ADMINISTRATION; POLYPOSIS; THERAPY;

ADOLESCENT; ADULT; CASE REPORT; COLONIC NEOPLASMS; DRUG EVALUATION; FEMALE; GARDNER SYNDROME; HUMAN; INDENES; INDOMETHACIN; MALE; SULINDAC; SUPPORT, NON-U.S. GOV'T;

EID: 0020565187     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.2930240119     Document Type: Article

References (47)

1. Indomethacin treatment of rats with dimethylhydrazine‐induced intestinal tumors
2. Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine
3. The inhibition by aspirin and indomethacin of osteolytic tumour deposits and hypercalcaemia in rats with Walker tumour and its possible application to human breast cancer
4. Prostaglandins and cyclic nucleotides in Moloney sarcoma tumors
5. Alterations of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse
6. Anti‐proliferative activity of anti‐inflammatory drugs in two mammalian cell culture lines
7. Mechanism of inhibition of tumour growth by aspirin and indomethacin
8. Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice
9. Cancer growth, response to treatment and survival time in mice: beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen
10. Prostaglandin synthesis inhibition: effect on bone changes and sarcoma tumor induction in BALB/c mice
11. Subversion of immune system by tumor cells and role of prostaglandins
12. Indomethacin and ascorbate inhibit desmoid tumors
13. Nonsteroid anti‐inflammatory drugs and tamoxifen for desmoid tumors and carcinoma of stomach
14. Prostaglandins and cancer
15. 2α on the growth of a hormone‐dependent rat mammary tumor
16. Inhibition of tumor growth in vivo and in vitro by prostaglandin E
17. Regression of head and neck carcinoma with a prostaglandin‐synthesis inhibitor
18. Skin cancers in xeroderma pigmentosum: Response to indomethacin and steroids
19. Treatment of intra‐abdominal and abdominal wall desmoid tumors with drugs that affect the metabolism of cyclic 3′,5′‐adenosine monophosphate
20. Familial polyposis of the colon: The fate of the retained rectum after colectomy in children
21. The role of ileal contents in the spontaneous regression of rectal adenomas
22. Spontaneous disappearance of rectal polyps following subtotal colectomy and ileoproctostomy for polyposis of the colon
23. Identification of the biologically active form of sulindac
24. The disposition of sulindac
25. Physiologic disposition and metabolic fate of a new anti‐inflammatory agent, cis‐5‐fluoro‐2‐methyl‐1[p‐(methylsulfinl)‐benzylidenl]‐idene‐3‐acetic acid in the rat, dog, rhesus monkey and man
26. Chemical and biological studies on indomethacin, sulindac and their analogs
27. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin‐like drugs
28. Studies on the absorption, distribution and excretion of indomethacin in various species
29. 1 phase of the cell cycle
30. 1 phase of the cell cycle by indomethacin
31. Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12‐O‐tetradecanoylphorbol‐13‐acetate
32. Cyclic AMP‐mediated induction of ornithine decarboxylase in normal and neoplastic growth
33. Indomethacin in submicromolar concentrations inhibits cyclic AMP dependent protein kinase
34. Studies on the regulation of ornithine decarboxylase activity by the microtubules: The effect of colchicine and vinblastine
35. Ornithine decarboxylase induction and the cytoskeleton in normal and transformed cells
36. Control of DNA synthesis and mitosis in 3T3 cells by cyclic AMP
37. Enhancement by purine nucleosides and nucleotides of serum induced DNA synthesis in quiescent 3T3 cells
38. Opposite effects of dibutyryl adenosine 3′:5′ cyclic monophosphate and serum on growth of Chinese hamster cells
39. The regulation of ornithine decarboxylase activity in intact normal and transformed cells maintained with a minimal salts/glucose medium
40. Regulation of ornithine decarboxylase activity by corticotropin in adrenocortical tumor cell clones: Role of cyclic AMP‐dependent protein kinase
41. Calcium and microtubule dependence for increased ornithine decarboxylase activity stimulated by β‐adrenergic agonists, dibutyryl cyclic AMP, or serum in a rat astrocytoma cell line
42. Inhibition of ornithine decarboxylase and S‐adenosyl methionine decarboxylase activities of S49 lymphoma cells by agents increasing cyclic AMP
43. Prostaglandins and host defense in cancer
44. The suppressor‐cell network in cancer I
45. The suppressor‐cell network in cancer II
46. Eukaryotic transcriptional regulation and chromatin‐associated protein phosphorylation by cyclic AMP
47. Proposed model of major sequential biochemical events of a trophic response